William Blair analyst Brian Weinstein downgrades DermTech (NASDAQ:DMTK) from Outperform to Market Perform.
EF Hutton Initiates Coverage On SHF Hldgs with Buy Rating, Announces Price Target of $10.5
EF Hutton analyst Michael Albanese initiates coverage on SHF Hldgs (NASDAQ:SHFS) with a Buy rating and announces Price Target of $10.5.